|Articles|May 1, 2000

Emerging Drug-Resistant Pathogens in Respiratory Tract Infections: Treatment Options
Volume 6
Issue 8 Suppl

Selected Abstracts

Download PDF: Selected Abstracts

Articles in this issue

about 26 years ago

Article

Participating Faculty

about 26 years ago

Article

Introduction

about 26 years ago

Article

Emerging Resistance Problems Among Respiratory Tract Pathogens

about 26 years ago

Article

The Challenge of Prescribing Treatment for Respiratory Tract Infections

about 26 years ago

Article

The Role of Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

about 26 years ago

Article

The Importance of Appropriate Treatment of Chronic Bronchitis

about 26 years ago

Article

Choosing the Ideal Antibiotic Therapy and the Role of the Newer Fluoroquinolones in Respiratory Tract Infections

about 26 years ago

Article

Bibliography

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Readability of Hospital Patient Financial Policy Documents

BySamantha Randall, BA,Sumedha Raghu, MS,Ella Cho,Nina Linh Nguyen, MHA,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

July 7th 2026

The Timing and Characteristics of Supplemental Indications for Medicines

ByYingying Zhu, PhD,Claire H. Brennan, BA,Haijun Tian, PhD,Josephine N. Tran, PharmD, MS,Peter J. Neumann, ScD,James D. Chambers, PhD,Pei-Jung Lin, PhD,Meng Li, PhD

July 6th 2026

State Medicaid Budgetary Implications of New Cancers

ByAmanda C. Chen, PhD,Anuraag R. Kansal, PhD,David C. Grabowski, PhD

July 2nd 2026

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

ByKaitlyn T. Haas, PharmD,Joseph J. Saseen, PharmD, BCPS, BCACP,Oliver Titus, MS,Nathan Lamberton, PharmD, BCACP,Lisa M. Schilling, MD, MSPH,Keri N. Hogan, PharmD, BCACP,Alison Marks, BA,Sarah J. Billups, PharmD, BCPS

July 1st 2026

Selected Abstracts

Articles in this issue

Related Content

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

The Timing and Characteristics of Supplemental Indications for Medicines

State Medicaid Budgetary Implications of New Cancers

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

Trending on AJMC

FDA Approves Atacicept for IgA Nephropathy

340B Drug Payment Cuts Headline CMS Proposal to Lower Medicare Costs

IL-6, Not hsCRP, Modified Lp(a)-Associated CAD Risk

Readability of Hospital Patient Financial Policy Documents

INCA033989 Shows Potential as a Targeted Approach for Myelofibrosis With Mutant Calreticulin: Claire Harrison, MD

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Selected Abstracts

Articles in this issue

Related Content

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

The Timing and Characteristics of Supplemental Indications for Medicines

State Medicaid Budgetary Implications of New Cancers

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

Trending on AJMC

FDA Approves Atacicept for IgA Nephropathy

340B Drug Payment Cuts Headline CMS Proposal to Lower Medicare Costs

IL-6, Not hsCRP, Modified Lp(a)-Associated CAD Risk

Readability of Hospital Patient Financial Policy Documents

INCA033989 Shows Potential as a Targeted Approach for Myelofibrosis With Mutant Calreticulin: Claire Harrison, MD